Position in NKTR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$580,132
-$2,042,757 QoQ
Shares Held
8,063
-92.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Sep 30, 2021CallValue
$1,796,000
CallShares
6,667
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in NKTR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $580,132 | 8,063 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $2,622,889 | 101,505 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $498,294 | 535,800 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $211,344 | 377,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $71,520 | 119,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,560 | 32,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,430 | 24,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $281,828 | 124,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $679,734 | 212,417 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $297,160 | 78,200 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $551,343 | 40,810 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,891,349 | 105,309 | Shares | Sole | 2021-11-16 | |
| 2021-09-30 | $1,796,000 | 100,000 | Call | Sole | 2021-11-16 | |
| 2021-06-30 | $1,009,505 | 58,829 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $963,980 | 48,199 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $1,227,642 | 53,007 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||